T1	location 247 261	North American
T2	intervention 20 28	palpable
T3	control 33 51	nonpalpable tumors
T4	eligibility 55 107	early-stage, hormone receptor-positive breast cancer
T5	intervention-participants 340 343	513
T6	control-participants 366 370	1063
T8	outcome 772 775	DFS
T9	outcome 780 782	OS
T10	outcome 846 849	DFS
T11	iv-bin-percent 850 855	93.5%
T12	cv-bin-percent 860 865	98.4%
T13	outcome 878 880	OS
T14	iv-bin-percent 881 886	88.5%
T15	cv-bin-percent 891 896	95.6%
